Search results
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study By...
Investing.com· 4 days agoAbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
AbbVie Lifts 2024 Forecast as Newer Drugs Replace Humira Losses
Bloomberg· 4 days agoAbbVie Inc. lifted its full-year profit guidance as newer anti-inflammatory treatments like Rinvoq...
Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
Zacks via Yahoo Finance· 5 days agoChicago, IL – April 25, 2024 – Today, Zacks Equity Research discusses Eli Lilly LLY, Novo Nordisk...
AbbVie (ABBV) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 3 days agoWhile the top- and bottom-line numbers for AbbVie (ABBV) give a sense of how the business performed...
Q1 2024 AbbVie Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 days agoParticipants Carrie C. Strom; Senior VP of AbbVie & President of Global Allergan Aesthetics; AbbVie Inc. Elizabeth Shea; SVP of IR; AbbVie</ ...
AbbVie Reports First-Quarter 2024 Financial Results
The Missourian· 4 days agoReports First-Quarter Diluted EPS of $0.77 on a GAAP Basis, an Increase of 492.3 Percent; Adjusted Diluted EPS of $2.31, a Decrease of 6.1 Percent; These Results Include an Unfavorable
AbbVie tries to reassure investors on Humira biosimilar threat
BioPharma Dive via Yahoo Finance· 4 days agoDive Brief: U.S. Humira sales fell 40% year over year during the first three months of 2024, to...
AbbVie Shares Close Down 4.6%, Sees Additional Humira Volume Erosion in 2Q
Market Watch· 3 days agoShares of AbbVie lost 4.6% to close at $159.62 on Friday after the company warned about the effects of losing the exclusivity of its patent for the arthritis medication Humira ...
AbbVie announces LEVEL UP results in atopic dermatitis study By Investing.com
Investing.com· 5 days agoThe study focused on adult and adolescent patients who had an inadequate response to systemic...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 4 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...